Skip to main content

Home/ Groups/ OARS funding Biomed
MiamiOH OARS

RFA-MH-19-121: Early Screening for Autism Spectrum Disorder (R21 Clinical Trial Not All... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to encourage research that would develop and validate new screening methods for autism spectrum disorders (ASD) that can be used in infancy (0-12 months of age). This FOA uses the R21 grant mechanism, while RFA- MH-19-120 uses the R01 grant mechanism. Applications with strong preliminary data proposing validation, refinement or final stages of testing of existing tools or methods may be more appropriate for the R01 mechanism. Pilot or exploratory projects with minimal preliminary data, or those proposing early-stage feasibility testing, may be more appropriate for this FOA (R21 mechanism).
MiamiOH OARS

RFA-NS-18-026: NINDS Morris K. Udall Centers of Excellence for Parkinsons Disease Resea... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) invites applications for the Morris K. Udall Centers of Excellence for Parkinson's Disease Research program. The overarching goal of the specialized Udall Centers program is to establish a network of Centers that work collaboratively as well as independently to define the causes of and discover improved treatments for Parkinson's disease (PD). A more immediate goal for each Center is to rapidly advance synergistic, interdisciplinary research programs while serving as national leaders in PD research. Udall Centers also serve as local resources by organizing research career enhancement activities for Center investigators and periodic outreach to the PD patient/advocacy community. Applicants are expected to identify and address an overall research theme that defines a critical challenge in PD research.
MiamiOH OARS

RFA-NS-18-027: NINDS Morris K. Udall Center without Walls for Parkinsons Disease Resear... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) requests Exploratory Grant (P20) applications for the planning and initiation of collaborative activities to advance Parkinson's Disease (PD) research. The goal of this FOA is to convene new transdisciplinary research consortia and formalize the multi-institutional organizational and investigational structure necessary to resolve an essential challenge in Parkinson's disease (PD) through a subsequent NINDS Udall Center without Walls (CWOW) approach. The most compelling applications will: (i) identify a fundamental PD research priority; (ii) build an exemplary research consortium; (iii) gather supportive preliminary data; and (iv) demonstrate exceptional potential to pursue a targeted strategy to remove a critical impediment blocking advancement of the understanding and treatment of PD.
MiamiOH OARS

ACVO Vision for Animals Foundation Invites Applications for Research | RFPs | PND - 0 views

  •  
    To advance this mission, the foundation awards grants of up to $5,000 in support of research on the elimination of ocular diseases causing vision loss and suffering in animals. Grant awards support the purchase of research supplies, materials, equipment (limited);, publication costs; and salary for technical support. Grant awards do not support the salary of the resident, the salary of the faculty mentor, tuition costs, major equipment purchases, or institutional indirect costs.
MiamiOH OARS

IAMSE Issues Call for 2018 Medical Science Education Scholarship Grant Program | RFPs |... - 0 views

  •  
    To advance this mission, the association is accepting applications for its 2018 educational scholarship grant program. Grants of up to $5,000 will be awarded in support of two-year medical science education research projects. The principal investigator of each funded project will be awarded an additional $1,500 travel award to present the results of their grant research at a future IAMSE meeting.
MiamiOH OARS

SFARI Seeks New Clinical Sites for Autism Research Network | RFPs | PND - 0 views

  •  
    SFARI is seeking to add additional clinical sites to its existing network for the purposes of recruiting SPARK participants. Selected sites will receive funding on an annual basis for up to three years, subject to periodic performance review. Support for a clinical site will include the following allowable costs: principal investigator salary - up to 10 percent effort for a PI or PI(s); site coordinator(s) salary - up to two full-time coordinators or the equivalent; funds for conducting community outreach in catchment area (excludes direct payment to participants); funds for recruitment and retention materials and supplies such as tablets to assist families with online registration; and, if applicable, funds to support return of genetic and behavioral results.
MiamiOH OARS

American Liver Foundation Seeks Applications for 2019 Research and Fellowship Awards | ... - 0 views

  •  
    Liver Scholar Award: Three-year grants of up to $225,000 will be awarded in support of basic science research projects. The goal is to provide young scientists with support at an early stage of their careers and help bridge the gap between completion of their research training and attainment of status as an independent research scientist. While applications on all liver-related research topics will be considered, preference will be given to projects related to biliary atresia and primary biliary cirrhosis.
MiamiOH OARS

Increasing Influenza and Tdap Vaccination of Pregnant Women in Obstetric/Gynecologic Pr... - 0 views

  •  
    This Notice of Funding Opportunity (NOFO) will support a randomized controlled trial (RCT) to evaluate the effectiveness of adult immunization quality improvement interventions to increase influenza and Tdap vaccination coverage among pregnant women in at least two gynecologic/obstetric (OB/GYN) practices (that stock influenza and Tdap vaccines) within a large health system in one or more state, local, or territorial public health jurisdiction(s).
MiamiOH OARS

Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U0... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) solicits applications for the Consortium on Targeting and Regeneration (CTAR) that supports the development of innovative strategies to increase or protect functional human beta cell mass in patients with Type-1 Diabetes (T1D) through the controlled manipulation of beta cell replication, islet cell plasticity, and the reprogramming of pancreatic non-beta cells into beta-like cells, or through shielding the residual beta cell mass from the autoimmune environment. CTAR is part of the Human Islet Research Network (HIRN).
MiamiOH OARS

Request for Applications - The Chan Zuckerberg Initiative - 0 views

  •  
    The Human Cell Atlas (HCA) is a global effort to create a reference map of all cell types in the human body. The Chan Zuckerberg Initiative and the Helmsley Charitable Trust are pleased to announce continued support for the Human Cell Atlas by collaborating on two new funding mechanisms that the community can access through a single application portal. The Chan Zuckerberg Initiative seeks to continue the work of the HCA community with a focus on interdisciplinary work and collaboration through the formation of 3 year Seed Networks. The Helmsley Charitable Trust welcomes applications that will construct a detailed atlas of the human gut. Project Specifications This Request for Applications (RFA) seeks to support the continued growth of nascent projects and to incubate new networks. The Seed Networks should generate new tools, open source analysis methods, and significant contributions of diverse data types to the Human Cell Atlas Data Coordination Platform. Applications should have a primary focus on the healthy tissues that will contribute to a reference atlas. Seed Networks Seed Networks should consist of at least three principal investigators, including at least one computational biologist or software engineer, together with additional computational biologists, engineers, experimental biologists, and/or physicians. CZI Seed Networks aim to support foundational tools and resources for the HCA and will not require a gut component in the application. CZI Seed Network Grants have four overarching scientific goals: - Build and support networks of collaborating scientists and engineers; - Contribution of high-quality data to v1.0 of the HCA; - Development of new technologies and benchmark data sets, particularly those anchored in spatial as well as molecular information; - Support of computational biology within the Human Cell Atlas community.
MiamiOH OARS

Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Le... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) encourages applications for Countermeasures Against Chemical Threats (CounterACT) Cooperative Agreement (U01) Research Projects for research on the identification of small molecule or biologic lead compounds that are excellent candidates for therapeutic development. The mission of the CounterACT program is to foster and support research and development of new and improved therapeutics for chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents, toxic industrial chemicals, pharmaceutical-based agents, and pesticides. The scope of research supported by this FOA includes confirmation of molecular targets for therapeutic development, demonstration of in vitro activity of candidate therapeutics, preliminary in vivo proof-of-concept efficacy data, preliminary adsorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) evaluations and pharmacokinetics/pharmacodynamics (PK/PD) data. These studies should result in the identification of at least one lead compound ready for optimization. Lead compounds are biologically active and synthetically feasible compounds where specificity, affinity, potency, target selectivity, efficacy, and safety have been established. Lead compounds should be ready for more advanced development under possible support from other programs such as the one described in the companion FOA "CounterACT Optimization of Therapeutic Lead Compound (U01)" (PAR-18-NNN). The scope of this FOA encompasses Technical Readiness Level (TRL) 1-3 - see TRLs. Each project must include annual milestones that create discrete go or no-go decision points in a progressive translational study plan.
MiamiOH OARS

NINDS Morris K. Udall Center without Walls for Parkinsons Disease Research (P20 Clinica... - 0 views

  •  
    This Funding Opportunity Announcement (FOA) requests Exploratory Grant (P20) applications for the planning and initiation of collaborative activities to advance Parkinson's Disease (PD) research. The goal of this FOA is to convene new transdisciplinary research consortia and formalize the multi-institutional organizational and investigational structure necessary to resolve an essential challenge in Parkinson's disease (PD) through a subsequent NINDS Udall Center without Walls (CWOW) approach. The most compelling applications will: (i) identify a fundamental PD research priority; (ii) build an exemplary research consortium; (iii) gather supportive preliminary data; and (iv) demonstrate exceptional potential to pursue a targeted strategy to remove a critical impediment blocking advancement of the understanding and treatment of PD. The stated challenge and related research feasibility projects will inform the etiology, pathogenesis or treatment of PD; investigations on related synucleinopathies may be included if such studies directly address the central PD research challenge. To foster the development of innovative research collaborations, this FOA will provide support for new research consortia only; continuation of established projects and teams will not be supported. Proposed consortia must include the optimal combination of specialized expertise required to resolve the stated challenge using a goal-driven approach. The Program Director/Principal Investigator (PD/PI) must be eminently qualified to provide visionary scientific leadership and effective oversight of consortium administrative activities. Participating investigators should be recognized as world-class experts in their fields. Teams must be anchored by at least one PD researcher. To maximize potential for new insights and incorporation of cutting-edge approaches, consortia will actively integrate at least one investigator with primary expertise in another, complementary research area.
MiamiOH OARS

Medical Scientist Training Program (T32) - 0 views

  •  
    The goal of the Medical Scientist Training Program (MSTP) is to develop a diverse pool of highly trained physician-scientist leaders available to meet the needs of the Nations biomedical research agenda. Specifically, this funding opportunity announcement (FOA) provides support to eligible domestic institutions to develop and implement effective, evidence-based approaches to integrated dual-degree training leading to the award of both professional medical doctorate degrees and research doctorate degrees (Ph.D. or equivalent). With the dual qualification of rigorous scientific research and clinical practice, graduates will be equipped with the skills to develop research programs that accelerate the translation of research advances to the understanding, detection, treatment and prevention of human disease, and to lead the advancement of biomedical research. Areas of particular importance to NIGMS are the iterative optimization of MSTP training efficacy and efficiency, fostering the persistence of MSTP alumni in research careers, and enhancing the diversity of the physician-scientist workforce. NIGMS expects that the proposed research training programs will incorporate didactic, research, mentoring and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation.
MiamiOH OARS

Initiative for Maximizing Student Development (IMSD) (T32) - 0 views

  •  
    The goal of the Initiative for Maximizing Student Development (IMSD) program is to develop a diverse pool of scientists earning a Ph.D., who have the skills to successfully transition into careers in the biomedical research workforce. The long-term goal of the program is to enhance the diversity of biomedical research scientists in the Nations workforce. This funding opportunity announcement (FOA) provides support to eligible, domestic institutions to develop and implement effective, evidence-based approaches to biomedical training and mentoring that will keep pace with the rapid evolution of the research enterprise. NIGMS expects that the proposed research training programs will incorporate didactic, research, and career development elements to prepare trainees for careers that will have a significant impact on the health-related research needs of the Nation. This program is limited to applications from training programs at research-intensive institutions (i.e., those with a 3-year average of NIH Research Project Grant funding equal to or above $7.5 million total costs).
MiamiOH OARS

Early Screening for Autism Spectrum Disorder (R01 Clinical Trial Not Allowed) - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to encourage research to develop and validate new screening methods for autism spectrum disorders (ASD) that can be used in infancy (0-12 months of age). This FOA uses the R01 grant mechanism, while RFA-MH-19-121 uses the R21 grant mechanism. Pilot or exploratory projects with minimal preliminary data, or those proposing early-stage feasibility testing, may be most appropriate for the R21 mechanism. Applicants with strong preliminary data proposing validation, refinement or final stages of testing of existing tools or methods may wish to use this FOA (R01 mechanism).
MiamiOH OARS

Paralyzed Veterans of America Education Foundation Invites Proposals for Innovative Edu... - 0 views

  •  
    Paralyzed Veterans of America advocates for better health care and benefits for paralyzed veterans, aids them in the search for a truly satisfying career, and provides them with a path to adventure through adaptive sports. Through its charitable arm, the Paralyzed Veterans of America Education and Training Foundation, the organization supports educational projects that benefit, serve, and enhance the quality of life of individuals with spinal cord injury/disease, their families, and caregivers. 
MiamiOH OARS

American Lung Association Accepting Applications for Research Grant | RFPs | PND - 0 views

  •  
    Through the program, grants of $50,000 per year for up to two years will be awarded to junior investigators on the path to independence for research on the mechanisms and biology of interstitial lung disease.The Dalsemer Research Grant is for $50,000 per year, for up to two years. Grants are subjected to annual review and may be granted for two years. The second year of support is based on demonstrating satisfactory progress, as well as, the availability of funding from the Lung Association. Applicants should be on-track to pursue a career in lung heath research with a mentor who has a demonstrated history of lung disease research and mentorship.
MiamiOH OARS

DDCF Accepting Pre-Proposals for Clinical Scientist Development Award | RFPs | PND - 0 views

  •  
    The CSDA program provides grants to junior physician scientists in any disease area to help facilitate their transition to an independent clinical research career. Competitive applicants are expected to have research experience and a publication record consistent with the rank of assistant professor. In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or primary tissues derived from animals will not be supported by the program.
MiamiOH OARS

PCORI Invites LOIs for Patient-Centered Healthcare Research | RFPs | PND - 0 views

  •  
    The Patient-Centered Outcomes Research Institute helps people make informed healthcare decisions and improves healthcare delivery and outcomes by producing and promoting high-integrity evidence-based information that comes from research guided by patients, caregivers, and the broader healthcare community. PCORI currently is inviting Letters of Inquiry for its Eugene Washington PCORI Engagement Awards program. Through the program, the institute will award grants of up to $250,000 over two years to projects that encourage active integration of patients, caregivers, clinicians, and other healthcare stakeholders as integral members of the patient-centered outcomes research/clinical effectiveness research (PCOR/CER) enterprise.
‹ Previous 21 - 40 of 2602 Next › Last »
Showing 20 items per page